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sentatives of national health authorities worldwide. The
ﬁrst recommendations were made by the Strategic Advisory
Group of Experts in November 2007.
doi:10.1016/j.ijid.2008.05.0462 13th Internat
ssociated marketing practices, migratory bird risks, and
ovement of people with their prized possessions: gifts in
he form of poultry or prize ﬁghting cocks. Maintenance of
he virus in chicken production systems seems to overlap
reas where rice production and duck husbandry coincide.
arly in February 2004 FAO offered a series of technical
rojects to assist countries and regions establish networks of
pidemiology units and veterinary diagnostic laboratories,
nd feed information into the WHO/Ministry of Health sys-
ems. The success was further emulated in Eastern Europe,
iddle East, Africa and the Americas through FAO’s own
unds and attracting vast support from multiple donors. The
uccess of an intervention measure is taken at the local level
o curb a poultry disease that affects people’s livelihoods
nd avoid a single human fatality from H5N1; but success
lso extends to the recognition of the veterinary services
s a Public Good and requires the political and ﬁnancial
esources for its rational development and ever-increasing
rofessionalism.
oi:10.1016/j.ijid.2008.05.044
.002
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nfection
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ndonesia
uman infection with Inﬂuenza A/H5N1 had been recog-
ized since a decade ago. It can be regarded as one of
ewly emerging infectious diseases. To date the disease has
ffected many countries worldwide. Hundreds of cases had
een reported to WHO with 50—60% fatalities. In Indone-
ia as of March 2008, 129 cases had been reported since
005 with inevitably high fatality rate (81,4%). Some pre-
iminary reports suggested that the high fatality rate may
orrelate with the virulence of the virus strain circulating
n the country, high viral load and the dissemination of the
irus into important organs outside the lung such as blood,
rain and the gastro-intestinal tract. New cases is still tak-
ng place in the country due to many factors: geographic
nd demographic, poultry farming structure, vaccine avail-
bility, poultry movement, geopolitical (decentralization
mpact) and migratory birds may plays some roles.
The demographic characteristic showed that all age
roups may be affected with slight predominance in young
dult group. There is no signiﬁcant different between male
nd female in term of prevalence. A proportion of the cases
about 50%) had history of direct contact with sick, healthy
r died poultry, 30% had history of indirect contact with poul-
ry in the environtment either sick or healthy. In about 20%
f the cases the history of contact to source of infection
ould not be concluded.
Fever, cough and breathlessness are the most frequent
ncountered clinical feature. For the purpose of screening
ome criterias for suspect are used: ILI, ARI or pneumonia
ith history of contact with AI source of infection, rapid pro-
ressive pneumonia leading to ARDS or fatality, unresponsive
neumonia treated adequately with antibiotics, clustering,
r when viral infection is likely (leucopenia, lymphopenia).l Congress on Infectious Diseases Abstracts (Invited Papers)
ntibiotics are used as initial treatment of CAP empiricly
nd when there is evidence of secondary bacterial infection.
ntiviral treatment with oseltamivir has limited clinical ben-
ﬁt especially when given earlier.
oi:10.1016/j.ijid.2008.05.045
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rogress on Global Preparedness for Inﬂuenza Pandemic,
HO
. Shindo
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HO and international experts believe that the world is
ow closer to another inﬂuenza pandemic than at any time
ince 1968. Since the re-emergence of the highly pathogenic
5N1 avian inﬂuenza virus in Southeast Asia in 2003, the
irus has rapidly spread to parts of Eurasia, Middle-East
nd Africa and entrenched in some countries. Consequently,
poradic or clusters of human infection with the virus has
een continuously reported with high case fatality propor-
ion. WHO has published various technical guidelines and
lanning guidance for Member States to better respond to
utbreaks and better prepared. The areas of work include
lobal surveillance, outbreak investigation, diagnosis, vac-
ine development, infection control, pharmacological and
linical management of patients, stockpile development
nd research coordination. There is an ongoing process
o revise and update the WHO inﬂuenza pandemic pre-
aredness plan based on increased scientiﬁc knowledge and
onsensus reached during the series of international consul-
ations.
The other major activity is to develop a protocol on the
apid operations to contain the initial emergence of pan-
emic inﬂuenza. The attempt is to stop the emergence of
n inﬂuenza pandemic at its source which is an extraordi-
ary operation that requires international support that is
nprecedented in history.
Now more than 100 Member States have developed
ational inﬂuenza preparedness plans and it is now the time
or testing the plans. WHO is working closely with partners
nd conducted some pilot excersised in high-risk countries.
he experienced gained through these exercises, statisti-
al analysis of past pandemics and modelling studies have
dentiﬁed some key public health actions.
Inﬂuenza vaccine development evolved rapidly than ever
efore, shedding lights on better preparedness. The use of
nter-pandemic vaccines and the global stockpile strategies
re being discussed among technical experts and repre-
